Articles

New Malaria Drugs to Be Approved, But Do They Work and Are They Safe?

Roger Bate | 05 Sep 2007 | TCS Daily

The market for treatments of malaria - which kills over one million people a year -- is of almost no commercial value: Although patients seek over 300 million treatments a year, and perhaps as many suffer without treatment, few legitimate drug companies make any money from the business. It is for this reason that one would typically be excited that new drugs to treat the disease, produced by Chinese firm Guilin Pharmaceutical, and Indian firm Ipca Laboratories have been approved by the World Health Organization. But recent history suggests that caution is very much in order.

A Field Report of Uganda's Efforts to Build a Comprehensive Malaria Control Program

Richard Tren, Roger Bate & Philip Coticelli | 04 Sep 2007 | Africa Fighting Malaria

Malaria is the leading cause of illness and death in Uganda. AFM visited the country in February, 2007 to conduct interviews and gauge progress in fighting the disease. With the help of the Global Fund to Fight AIDS, TB and Malaria, the World Bank, the US Agency for International Development, the UK Department for International Development and other donors, the national government is scaling up existing treatment and prevention efforts while also developing a country-wide indoor residual spraying program.

DDT use should not be politicised

Carlos Odora | 02 Sep 2007 | New Vision

On August 14, The New Vision reported that the people spraying houses in Munyonyo to control malaria were "resisted". This incident highlights the need for good information, education and communication in malaria control and also provides evidence of the damage that the highly politicised and damaging debate around the use of DDT has done for malaria control. 

Indoor Residual Spraying - Do it right

| 24 Aug 2007 | Africa Fighting Malaria

On August 14, 2007 Uganda's New Vision newspaper reported that malaria control spraymen were "resisted" in Munyonyo, a suburb of Kampala, as they attempted to conduct an indoor residual spraying program. This incident highlights the need for good information, education and communication in malaria control and also provides evidence of the damage that the highly politicized and damaging debate around the use of DDT has done for malaria control.

Promises, promises and donor aid money

Richard Tren & Jasson Urbach | 20 Aug 2007 | MoneyWeb

It is estimated that the three major communicable diseases, malaria, HIV/AIDS, and TB, kill approximately 16,000 people every day. G8 leaders have promised to spend $60 billion to fight them, but in reality there is little behind this promise. Of the promised $60 billion it seems that only $15 billion is new money committed by the United States.

AFM Report: East and Southern Africa Malaria Control Conference

Richard Tren & Jasson Urbach | 16 Aug 2007 | Africa Fighting Malaria

AFM reports on the meeting of National Malaria Control Program Officials at the East and Southern African Malaria Control Conference, where new data was shared and control strategies discussed.

Uganda still needs to fight malaria

Carlos Odora | 01 Aug 2007 | New Vision

Malaria kills between 320-350 Ugandans daily. If these mortalities were accident induced, we would see tremendous national concern to halt them. Our best shot at the target is operating 300 pharmacies, 5,000 drug stores and the many private clinics, which according to the Uganda Bureau of Statistics, dispense up to 60% of the anti-malarials through the private sector.

Is it possible to eliminate malaria in South Africa?

Jasson Urbach | 27 Jun 2007 | Free Market Foundation

The debate over eradication versus control has been played out before and politicians hoping to hitch their wagons to the eradication star would do well to understand some of the important disease control history.

AFM Commentary and Policy Recommendations on Counterfeit and Substandard Medicines

None | 20 Jun 2007 | Africa Fighting Malaria

Around the globe, the production and distribution of substandard and counterfeit drugs is a vast, increasing and largely underreported, problem. Adulterated medicines contain little or none of the active ingredients found in their branded equivalent, and often have adverse health effects.

Global Business Coalition on HIV/AIDS, Tuberculosis & Malaria Awards

None | 15 Jun 2007 | Africa Fighting Malaria

The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria held its annual award ceremony in splendid style at the Natural History Museum in New York City.  The star-studded event was chaired by Amy Robbins and included speeches by Richard Branson and a rapping duet by Jamie Foxx and Doug E. Fresh...